Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06511323
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-06-27
Brief Title:
Evaluation of Brain Metastases Treated With Stereotactic Radiotherapy Using Dynamic 18FFDG PET
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluation of Brain Metastases Treated With Stereotactic Radiotherapy Using Dynamic 18FFDG PET
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the clinical usefulness of dynamic 18FFDG PET imaging in assessing brain metastasis post stereotactic radiotherapy to separate true progression from the treatment-related changes
Detailed Description:
After being informed about the study and potential risk all participants giving written informed consent will be screened to determine if participant being referred fits eligibility criteria for the study under of the supervision of the radiation oncologist If a participant agrees to participate in this study they will receive three additional imaging sessions the dynamic PET scan The first session will occur prior to starting treatment the second session will occur at about 10 weeks post treatment the third session will occur at first concern of progression at treated lesions or 12 months post-treatment whichever comes earlier These scans will be scheduled in addition to the participants regular follow-up scans and appointments
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None